A Pilot Prevention Study of the Effects of the Anti-progestin Ulipristal Acetate (UA) on Surrogate Markers of Breast Cancer Risk
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 14 Sep 2016
At a glance
- Drugs Ulipristal (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms BC-APPS1
- 07 Jun 2017 Biomarkers information updated
- 02 Jun 2016 Status changed from recruiting to active, no longer recruiting.
- 21 Feb 2016 Status changed from not yet recruiting to recruiting, according to United Kingdom Clinical Research Network record.